Inhibition of ATP-sensitive potassium channels attenuates propofol-induced vasorelaxation

Critical Care and Resuscitation

Volumn 12, Issue 3, 2010, Pages 186-190

  Lam, Chen Fuh ^a   Chang, Pei Jung ^a   Chen, Yung An ^a   Yeh, Chin Yi ^b   Tsai, Yu Chuan ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b Chest Hospital Health Executive Yuan   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; POTASSIUM CHANNEL; PROPOFOL; VASODILATOR AGENT;

ANIMAL; DOSE RESPONSE; SPRAGUE DAWLEY RAT; VASODILATATION;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; KATP CHANNELS; POTASSIUM CHANNELS; PROPOFOL; RATS, SPRAGUE-DAWLEY; VASODILATION; VASODILATOR AGENTS;

EID: 80054761388     PISSN: 14412772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. 1 Bryson HM, Fulton BR, Faulds D. Propofol: an update of its use in anaesthesia and conscious sedation. Drugs 1995; 50: 513-59.
2. 2 Sebel PS. Propofol: a new intravenous anesthetic. Anesthesiology 1989; 71: 260-77.
3. 3 Boillot A, Haddad E, Vallet B, et al. [Effects of anesthetic agents on arterial reactivity] [in French]. Ann Fr Anesth Reanim 1999; 18: 415-29.
4. 4 Wallerstedt SM, Törnebrandt K, Bodelsson M. Relaxant effects of propofol on human omental arteries and veins. Br J Anaesth 1998; 80: 655-9.
5. 5 Nagakawa T, Yamazaki M, Hatakeyama N, et al. The mechanisms of propofol-mediated hyperpolarization of in situ rat mesenteric vascular smooth muscle. Anesth Analg 2003; 97: 1639-45.
6. 6 Bodelsson G, Sandstrom K, Wallerstedt SM, et al. Effects of propofol on substance P-induced relaxation in isolated human omental arteries and veins. Eur J Anaesthesiol 2000; 17: 720-8.
7. 7 Kinoshita H, Katusic ZS. Role of potassium channels in relaxations of isolated canine basilar arteries to acidosis. Stroke 1997; 28: 433-8.
8. 8 Kinoshita H, Iranami H, Kimoto Y, et al. Cibenzoline has an inhibitory effect on vasorelaxation mediated by adenosine triphosphate- sensitive K(+) channels in the rat carotid artery. Anesth Analg 2001; 93: 282-6.
9. 9 June CH, Moore JS. Measurement of intracellular ions by flow cytometry. Curr Protoc Immunol 2004; Chapter 5: Unit 5.5.
10. 10 Boer F, Ros P, Bovill JG, et al. Effect of propofol on peripheral vascular resistance during cardiopulmonary bypass. Br J Anaesth 1990; 65: 184-9.
11. 11 Klockgether-Radke AP, Frerichs A, Kettler D, et al. Propofol and thiopental attenuate the contractile response to vasoconstrictors in human and porcine coronary artery segments. Eur J Anaesthesiol 2000; 17: 485-90.
12. 12 Klockgether-Radke AP, Schulze H, Neumann P, et al. Activation of the K+ channel BK(Ca) is involved in the relaxing effect of propofol on coronary arteries. Eur J Anaesthesiol 2004; 21: 226-30.
13. 13 Moreno L, Martinez-Cuesta MA, Muedra V, et al. Role of the endothelium in the relaxation induced by propofol and thiopental in isolated arteries from man. J Pharm Pharmacol 1997; 49: 430-2.
14. 14 Chang KS, Davis RF. Propofol produces endothelium-independent vasodilation and may act as a Ca2+ channel blocker. Anesth Analg 1993; 76: 24-32.
15. 15 Park KW, Dai HB, Lowenstein E, et al. Propofol-associated dilation of rat distal coronary arteries is mediated by multiple substances, including endothelium-derived nitric oxide. Anesth Analg 1995; 81: 1191-6.
16. 16 Ledoux J, Werner ME, Brayden JE, et al. Calcium-activated potassium channels and the regulation of vascular tone. Physiology (Bethesda) 2006; 21: 69-78.
17. 17 Samaha FF, Heineman FW, Ince C, et al. ATP-sensitive potassium channel is essential to maintain basal coronary vascular tone in vivo. Am J Physiol 1992; 262: C1220-7.
18. 18 Brayden JE. Functional roles of KATP channels in vascular smooth muscle. Clin Exp Pharmacol Physiol 2002; 29: 312-6.
19. 19 Shafer A, Doze VA, Shafer SL, et al. Pharmacokinetics and pharmacodynamics of propofol infusions during general anesthesia. Anesthesiology 1988; 69: 348-56.
20. 20 Larsson JE, Wahlstrom NM. Optimum rate of administration of propofol for induction of anaesthesia in rats. Brit J Anaesth 1994; 73: 692-4.
21. 21 Teramoto N. Pharmacological profile of U-37883A, a channel blocker of smooth muscle-type ATP-sensitive K channels. Cardiovasc Drug Rev 2006; 24: 25-32.
22. 22 Kane GC, Lam CF, O’Cochlain F, et al. Gene knockout of the KCNJ8-encoded Kir6. 1 K(ATP) channel imparts fatal susceptibility to endotoxemia. FASEB J 2006; 20: 2271-80.